Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The WD repeat domain, phosphoinositide interacting 2 pseudogene (**ENSG00000270993**) is a genomic sequence related to the functional *WIPI2* gene, which encodes a WD40 repeat protein involved in autophagy[1][3]. Pseudogenes are typically non-functional DNA segments derived from ancestral genes and do not produce active proteins or participate directly in biological processes or disease[1][3][10]. Most published information concerning "WD repeat domain, phosphoinositide interacting 2" (WIPI2) applies to the protein-coding gene rather than its pseudogene, which is not considered a therapeutic target, biomarker, or pharmacological entity[1][3][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain, phosphoinositide interacting 2 pseudogene (WIPI2 pseudogene (not commonly abbreviated; WIPI2 is for the functional gene)).